Beijing SciTech Pharmaceutical

Beijing SciTech Pharmaceutical is a specialized pharmaceutical company based in China that focuses on the research, development, and manufacturing of high-end generic and innovative drugs, particularly in the cardiovascular and chronic disease sectors. As a core subsidiary of China Resources Double-Crane Pharmaceutical, the company operates large-scale GMP-certified facilities for the production of solid oral dosages and active pharmaceutical ingredients. Its product portfolio is anchored by leading treatments for hypertension and hyperlipidemia, including widely used angiotensin receptor blockers and statins. Beijing SciTech is recognized for its strong R&D capabilities in chemical synthesis and its significant market share in the Chinese domestic cardiovascular market.